Log in

Relevant bibliographies by topics / Urinary bladder transitional cell carcinoma. eng / Journal articles

To see the other types of publications on this topic, follow the link: Urinary bladder transitional cell carcinoma. eng.

Journal articles on the topic 'Urinary bladder transitional cell carcinoma. eng'

Author: Grafiati

Published: 4 June 2021

Last updated: 14 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Urinary bladder transitional cell carcinoma. eng.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Wang, J., F. Wang, and C. A. Enke. "Effect of signet-ring cell carcinoma histology on bladder cancer outcome." Journal of Clinical Oncology 29, no. 7_suppl (2011): 275. http://dx.doi.org/10.1200/jco.2011.29.7_suppl.275.

Full text

Abstract:

275 Background: Signet-ring cell carcinoma (SRCC) of the urinary bladder is a rare entity. Recent case series of the condition showed inconsistent results. We used a population-based data set to compare the cancer specific survival of patients with signet-ring cell carcinoma vs. transitional cell carcinoma (TCC) of the urinary bladder. Methods: Signet-ring cell carcinoma of the urinary bladder and transitional carcinoma of the urinary bladder were identified in the Surveillance, Epidemiology and End Results program (2001 to 2004). Demographic and pathological characteristics at diagnosis were

APA, Harvard, Vancouver, ISO, and other styles

2

Park, Yong Hyun, Sung Yul Park, and Hyeon Hoe Kim. "Laparoendoscopic Single-Site Nephroureterectomy with Bladder Cuff Excision for Upper Urinary Tract Transitional-Cell Carcinoma: Technical Details Based on Oncologic Principles." Journal of Endourology 24, no. 4 (2010): 563–66. http://dx.doi.org/10.1089/end.2009.0502.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Challapalli, Amarnath, Susan Masson, Paul White, et al. "Pathological response rates and quality of life outcomes of neoadjuvant cabazitaxel and cisplatin chemotherapy for muscle-invasive transitional cell carcinoma of the urinary bladder." Journal of Clinical Oncology 38, no. 15_suppl (2020): 5030. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.5030.

Full text

Abstract:

5030 Background: Neoadjuvant cisplatin-based combination chemotherapy (NAC) improves survival in muscle invasive bladder cancer (MIBC). However, response rates and survival remain suboptimal. We sought to evaluate the efficacy, safety and tolerability of cisplatin cabazitaxel combination in this patient group. Methods: A phase 2 single arm trial (Simon 2 stage), to recruit at least 26 evaluable patients was designed with 80% power to detect the primary endpoint, objective response rate (ORR) of > 35%. ORR was defined as pathological complete response (pCR) plus partial response (pathologica

APA, Harvard, Vancouver, ISO, and other styles

4

Lehmann, Jan, Margitta Retz, Christina Wiemers, et al. "Adjuvant Cisplatin Plus Methotrexate Versus Methotrexate, Vinblastine, Epirubicin, and Cisplatin in Locally Advanced Bladder Cancer: Results of a Randomized, Multicenter, Phase III Trial (AUO-AB 05/95)." Journal of Clinical Oncology 23, no. 22 (2005): 4963–74. http://dx.doi.org/10.1200/jco.2005.11.094.

Full text

Abstract:

Purpose Radical cystectomy as standard treatment of muscle-invasive urothelial carcinoma of the urinary bladder cures less than 50% of patients with locally advanced bladder cancer. We compared two adjuvant combination chemotherapies in patients with stage pT3a-4a and/or pathologic node-positive transitional-cell carcinoma of the bladder after radical cystectomy. Patients and Methods A total of 327 patients were randomly assigned to either adjuvant systemic chemotherapy with three cycles of cisplatin 70 mg/qm2 on day 1 and methotrexate 40 mg/qm2 on days 8 and 15 of a 21-day cycle (CM) or three

APA, Harvard, Vancouver, ISO, and other styles

5

Li, Wei, Haitao Xiao, Xuewen Xu, and Yange Zhang. "The Impact of Radiotherapy on the Incidence of Secondary Malignancies: A Pan-Cancer Study in the US SEER Cancer Registries." Current Oncology 28, no. 1 (2021): 301–16. http://dx.doi.org/10.3390/curroncol28010035.

Full text

Abstract:

The population of cancer patients with second primary malignancies (SPMs) is rapidly growing. The relationship between radiotherapy and SPMs for some types of tumors is unknown or debated. In this study, we identify 24 types of first primary malignancies (FPMs) between 2004 and 2015 in the Surveillance, Epidemiology, and End Results (SEER) database. Patients in the radiotherapy group were matched to those in the no radiotherapy group with a matching ratio of 1:1. After propensity-score matching (PSM), additional competing risk regression analyses were performed to calculate the efficacy of rad

APA, Harvard, Vancouver, ISO, and other styles

6

Ro, Jae Y., Steven S. Shen, Hyang I. Lee, et al. "Plasmacytoid Transitional Cell Carcinoma of Urinary Bladder." American Journal of Surgical Pathology 32, no. 5 (2008): 752–57. http://dx.doi.org/10.1097/pas.0b013e318159af9e.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Hamlin, Alessandra N., Laura E. Chadwick, Stacey A. Fox‐Alvarez, and Eric T. Hostnik. "Ultrasound characteristics of feline urinary bladder transitional cell carcinoma are similar to canine urinary bladder transitional cell carcinoma." Veterinary Radiology & Ultrasound 60, no. 5 (2019): 552–59. http://dx.doi.org/10.1111/vru.12777.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Krpina, Kristian. "Immunotherapy of transitional cell carcinoma of urinary bladder." Medicina fluminensis 53, no. 3 (2017): 314–19. http://dx.doi.org/10.21860/medflum2017_182956.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Mitsogiannis, Iraklis C., Maria G. Ioannou, Chrissanthi D. Sinani, and Michael D. Melekos. "Plasmacytoid transitional cell carcinoma of the urinary bladder." Urology 66, no. 1 (2005): 194. http://dx.doi.org/10.1016/j.urology.2005.01.023.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

López, J. I., K. Elorriaga, I. Imaz, and F. J. Bilbao. "Micropapillary transitional cell carcinoma of the urinary bladder." Histopathology 34, no. 6 (1999): 561–62. http://dx.doi.org/10.1111/j.1365-2559.1999.0696f.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Karan, S. C., Amit Kumar Shah, Anand Srivastava, and Reena Bhardwaj. "Primary amyloidosis of urinary bladder: Mimicking transitional cell carcinoma bladder?" Medical Journal Armed Forces India 72, no. 1 (2016): 91–93. http://dx.doi.org/10.1016/j.mjafi.2014.11.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Kuroda, Masao, Shigeru Saiki, Toshiaki Kinouchi, et al. "TREATMENT OF TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER." Japanese Journal of Urology 79, no. 3 (1988): 507–12. http://dx.doi.org/10.5980/jpnjurol1928.79.3_507.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Hafez, Fatma S. S., Nadia B. Mahmoad, Ragaa A. Fawzy, Hala S. Cousha, and Riham M. Abu-Zeid. "Aurora-A in transitional cell carcinoma of urinary bladder." Egyptian Journal of Pathology 36, no. 1 (2016): 23–28. http://dx.doi.org/10.1097/01.xej.0000482437.08143.a7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Sakr, Wael A., David J. Grignon, and John D. Crissman. "Histopathology of transitional cell carcinoma of the urinary bladder." Current Opinion in Urology 7, no. 5 (1997): 287–92. http://dx.doi.org/10.1097/00042307-199709000-00009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Anderson, Russell Scott, Anas M. El Mahdi, Deborah A. Kuban, and Elizabeth M. Higgins. "Brain metastases from transitional cell carcinoma of urinary bladder." Urology 39, no. 1 (1992): 17–20. http://dx.doi.org/10.1016/0090-4295(92)90034-t.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Bugeja, Mark, Christine Mizzi, Ernest Ellul, Simon Bugeja, and Stephen Mattocks. "Enterovesical Fistula Secondary to Transitional Cell Carcinoma of the Bladder." Surgery Journal 04, no. 04 (2018): e201-e204. http://dx.doi.org/10.1055/s-0038-1673663.

Full text

Abstract:

AbstractAlthough fistulae between the urinary bladder and the gastrointestinal tract are not uncommon, those caused by carcinoma of the urinary bladder are rare. This report describes the case of an 85 years old male who was diagnosed with a mass involving the small bowel and the urinary bladder during the course of investigation for recurrent urinary tract infections. At laparotomy, the presence of an enterovesical fistula involving the ileum and bladder was confirmed. Histopathological examination of the resected mass showed poorly differentiated urothelial carcinoma. No early postoperative

APA, Harvard, Vancouver, ISO, and other styles

17

Volkogon, Andrii, Olena Kolnoguz, Viktoriia Harbuzova, and Alexander Ataman. "Long Non-Coding RNA MALAT1 Gene Polymorphism is Associated with Disease-Free Survival in Bladder Cancer Patients." Galician Medical Journal 27, no. 2 (2020): E202025. http://dx.doi.org/10.21802/gmj.2020.2.5.

Full text

Abstract:

The objective of the research was to study the possible association between MALAT1 gene rs3200401 polymorphism and the survival of patients with bladder cancer and clinicopathological characteristics in bladder cancer. Materials and Methods. The venous blood of 141 patients with transitional cell carcinoma of the urinary bladder was used for study. Genotyping of MALAT1 gene rs3200401 polymorphism was performed by real-time polymerase chain reaction using the 7500 Fast Real-Time PCR System (Applied Biosystems, Foster City, USA) and Taq-Man Assays (TaqMan® SNP Assay C_3246069_10). Statisti

APA, Harvard, Vancouver, ISO, and other styles

18

Alexander, P. W., C. Sanders, and H. Nath. "Cavitary pulmonary metastases in transitional cell carcinoma of urinary bladder." American Journal of Roentgenology 154, no. 3 (1990): 493–94. http://dx.doi.org/10.2214/ajr.154.3.2106210.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Reshi, A. R., S. A. Mir, A. A. Gangoo, S. Shah, and K. Banday. "Nephrotic Syndrome Associated with Transitional Cell Carcinoma of Urinary Bladder." Scandinavian Journal of Urology and Nephrology 31, no. 3 (1997): 295–96. http://dx.doi.org/10.3109/00365599709070351.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Chen, K. T. K. "Coexisting Leiomyosarcoma and Transitional Cell Carcinoma of the Urinary Bladder." Journal of Urology 137, no. 2 (1987): 365. http://dx.doi.org/10.1016/s0022-5347(17)44026-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Parham, D. M., K. Morton, G. Coghill, A. J. Robertson, and M. A. Kerr. "Expression of CD15 antigen in urinary bladder transitional cell carcinoma." Journal of Clinical Pathology 43, no. 7 (1990): 541–43. http://dx.doi.org/10.1136/jcp.43.7.541.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Gupta, Narmada P., and Anup Kumar. "ROBOTIC MANAGEMENT OF TRANSITIONAL CELL CARCINOMA IN URINARY BLADDER DIVERTICULUM." Journal of Urology 179, no. 4S (2008): 709. http://dx.doi.org/10.1016/s0022-5347(08)62066-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Young, Robert H., and Mark R. Wick. "Transitional Cell Carcinoma of the Urinary Bladder with Pseudosarcomatous Stroma." American Journal of Clinical Pathology 90, no. 2 (1988): 216–19. http://dx.doi.org/10.1093/ajcp/90.2.216.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Ylagan, Lourdes R., and Peter A. Humphrey. "Micropapillary Variant of Transitional Cell Carcinoma of the Urinary Bladder." Acta Cytologica 45, no. 4 (2001): 599–604. http://dx.doi.org/10.1159/000327871.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Chen, Karl T. K. "Coexisting leiomyosarcoma and transitional cell carcinoma of the urinary bladder." Journal of Surgical Oncology 33, no. 1 (1986): 36–37. http://dx.doi.org/10.1002/jso.2930330110.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Cetinkaya, Erdogan, Mehmet Akif Özgül, Ertan Cam, Atayla Gençoğlu, Güler Özgül, and Sule Gül. "Endobronchial Metastasis From Transitional Cell Carcinoma of the Urinary Bladder." Journal of Bronchology & Interventional Pulmonology 18, no. 2 (2011): 158–60. http://dx.doi.org/10.1097/lbr.0b013e318216d32d.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Radopoulos, Demetrios, Konstantinos Kalyvas, Rodi Kotakidou, Konstantina Panagiotopoulou, Vasilios Katsikas, and Michalis Papathanasiou. "Case report: Microcystic Transitional Cell Carcinoma of the Urinary Bladder." International Urology and Nephrology 37, no. 2 (2005): 291–93. http://dx.doi.org/10.1007/s11255-004-7968-y.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Beels, E., F. Van der Aa, B. Van Cleynenbreugel, and S. Joniau. "UP-03.141 Concomitant Transitional Cell Carcinoma of the Bladder in Patients with Urinary Tract Transitional Cell Carcinoma." Urology 78, no. 3 (2011): S390. http://dx.doi.org/10.1016/j.urology.2011.07.1230.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Leroy, Xavier, Emmanuelle Leteurtre, Alexandre De La Taille, David Augusto, Jacques Biserte, and Bernard Gosselin. "Microcystic Transitional Cell Carcinoma." Archives of Pathology & Laboratory Medicine 126, no. 7 (2002): 859–61. http://dx.doi.org/10.5858/2002-126-0859-mtcc.

Full text

Abstract:

Abstract Microcystic transitional cell carcinoma is a rare variant of urothelial carcinoma; to date, it has been described only in the urinary bladder. We report 2 cases of microcystic transitional cell carcinoma arising in the renal pelvis. The first case occurred in a 73-year-old man with a history of superficially invasive transitional cell carcinoma who presented with macroscopic hematuria and anemia. The second case occurred in a 62-year-old woman who had no relevant medical history and presented with hematuria. Computed tomographic scan revealed a tumor of the renal pelvis. In both cases

APA, Harvard, Vancouver, ISO, and other styles

30

Srinath, N., US Dinesh, and GP Sharma. "A Case of Synchronous Renal Cell Carcinoma (Rt) and Transitional Cell Carcinoma Urinary Bladder." Medical Journal Armed Forces India 62, no. 2 (2006): 190–91. http://dx.doi.org/10.1016/s0377-1237(06)80071-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Qayoom, Sumaira, Deep Chakrabarti, Fatima Khan, and Madhu Mati Goel. "Primary small cell carcinoma of the urinary bladder." BMJ Case Reports 12, no. 9 (2019): e230185. http://dx.doi.org/10.1136/bcr-2019-230185.

Full text

Abstract:

Small cell carcinoma of the urinary bladder (SCCB) is an extremely rare but aggressive tumour constituting less than 0.7% of all urinary bladder tumours. It is often misdiagnosed as transitional cell carcinoma, owing to the similarities in presentation. Diagnosis of SCCB is based on the WHO criteria for small cell lung carcinoma. A 58-year-old man who had presented with haematuria and burning micturition for 3 months was initially diagnosed as high-grade muscle-invasive urothelial carcinoma based on the TURBT specimen. The patient was put on neoadjuvant chemotherapy, but presented again with h

APA, Harvard, Vancouver, ISO, and other styles

32

Michaelson, M. D., W. U. Shipley, N. M. Heney, A. L. Zietman, and D. S. Kaufman. "Selective bladder preservation for muscle-invasive transitional cell carcinoma of the urinary bladder." British Journal of Cancer 90, no. 3 (2004): 578–81. http://dx.doi.org/10.1038/sj.bjc.6601580.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Journal, Baghdad Science. "Role of TGF-?1 in Urinary Bladder Carcinoma." Baghdad Science Journal 11, no. 4 (2014): 1481–85. http://dx.doi.org/10.21123/bsj.11.4.1481-1485.

Full text

Abstract:

The present study aimed to evaluate sera TGF- ?1 concentration in patients with urinary bladder carcinoma (UBC). All malignant of them was transitional cell carcinoma (TCC) type , patients with urinary bladder disorders (UBD ) and healthy control , and to study the correlation between sera TGF-?1 levels and tumor stages and grades in UBC patients . A direct ELISA test was used to quantify the seraTGF-?1 concentrations in sera of 58 patients with urinary bladder carcinoma UBC of different grades (G) and stages (T) all malignant of them was transitional cell carcinoma (TCC) type , 15 from patien

APA, Harvard, Vancouver, ISO, and other styles

34

Tekes, Aylin, Ihab R. Kamel, Khursheed Imam, Theresa Y. Chan, Mark P. Schoenberg, and David A. Bluemke. "MR Imaging Features of Transitional Cell Carcinoma of the Urinary Bladder." American Journal of Roentgenology 180, no. 3 (2003): 771–77. http://dx.doi.org/10.2214/ajr.180.3.1800771.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Tsushima, Tomoyasu. "BLOOD GROUP ISOANTIGENS IN TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER." Japanese Journal of Urology 90, no. 1 (1999): 5–11. http://dx.doi.org/10.5980/jpnjurol1989.90.5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Adamson, A. S., J. L. Francis, O. S. Roath, R. O’n Witherow, and M. E. Snell. "Urinary Tissue Factor Levels in Transitional Cell Carcinoma of the Bladder." Journal of Urology 148, no. 2 Part 1 (1992): 449–52. http://dx.doi.org/10.1016/s0022-5347(17)36626-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Siriwardena, B. S. M. S., W. M. Tilakaratne, and R. M. S. K. Rajapaksa. "Metastatic transitional cell carcinoma of the urinary bladder to the mandible." Oral Oncology Extra 41, no. 2 (2005): 22–24. http://dx.doi.org/10.1016/j.ooe.2004.10.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Singh, GautamK, DS Mulajker, Debraj Sen, and MS Suresh. "Acanthosis nigricans associated with transitional cell carcinoma of the urinary bladder." Indian Journal of Dermatology 56, no. 6 (2011): 722. http://dx.doi.org/10.4103/0019-5154.91837.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Koh, Kenneth B. H., Karol Rogawski, and Philip H. Smith. "Cavitating Pulmonary Metastases from Superficial Transitional Cell Carcinoma of Urinary Bladder." Scandinavian Journal of Urology and Nephrology 28, no. 2 (1994): 201–2. http://dx.doi.org/10.3109/00365599409180502.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Mitchell, I., S. Hayward, N. Deshpande, and J. M. Towler. "Enzyme Studies in Human Transitional Cell Carcinoma of the Urinary Bladder." Journal of Urology 141, no. 5 (1989): 1234–37. http://dx.doi.org/10.1016/s0022-5347(17)41228-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Fragkoulis, C., I. Glykas, G. Theoxaris, G. Stathouros, G. Papadopoulos, and K. Ntoumas. "Urinary bladder transitional cell carcinoma in patients of age below 40." European Urology Supplements 17, no. 11 (2018): e2595. http://dx.doi.org/10.1016/s1569-9056(18)33433-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Paik, Seung-Sam, and Moon-Hyang Park. "The nested variant of transitional cell carcinoma of the urinary bladder." BJU International 78, no. 5 (1996): 793–94. http://dx.doi.org/10.1046/j.1464-410x.1996.24527.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

GOHJI, KAZUO, YUKITO HASUNUMA, AKINOBU GOTOH, HIROYOSHI SHIMOGAKI, and SADAO KAMIDONO. "ACANTHOSIS NIGRICANS ASSOCIATED WITH TRANSITIONAL CELL CARCINOMA OE THE URINARY BLADDER." International Journal of Dermatology 33, no. 6 (1994): 433–35. http://dx.doi.org/10.1111/j.1365-4362.1994.tb04046.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

TINIAKOS, D. G., K. MELLON, J. J. ANDERSON, M. C. ROBINSON, D. E. NEAL, and C. H. W. HORNE. "c-junoncogene expression in transitional cell carcinoma of the urinary bladder." British Journal of Urology 74, no. 6 (1994): 757–61. http://dx.doi.org/10.1111/j.1464-410x.1994.tb07121.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Khan, M. A., W. Tao, P. Mathews, and B. S. Potluri. "Penile Metastasis Arising from Transitional Cell Carcinoma of the Urinary Bladder." Urologia Internationalis 66, no. 3 (2001): 162–63. http://dx.doi.org/10.1159/000056599.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Fynn-Thompson, Nicoletta, James M. McKiernan, and Aaron Fay. "Transitional Cell Carcinoma of the Urinary Bladder Metastatic to the Orbit." Ophthalmic Plastic & Reconstructive Surgery 19, no. 2 (2003): 165–67. http://dx.doi.org/10.1097/01.iop.0000056026.84209.1b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Rovirosa, A., A. Salud, E. Felip, F. Capdevila, J. Giralt, and J. Bellmunt. "Cavitary Pulmonary Metastases in Transitional Cell Carcinoma of the Urinary Bladder." Urologia Internationalis 48, no. 1 (1992): 102–4. http://dx.doi.org/10.1159/000282306.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Kozman, D., S. Heneidi, A. Ullah, I. Ghleilib, L. Vemavarapu, and T. Dykes. "Urinary Bladder Transitional Cell Carcinoma with Chordoid Features-A Rare Entity." American Journal of Clinical Pathology 154, Supplement_1 (2020): S56—S57. http://dx.doi.org/10.1093/ajcp/aqaa161.122.

Full text

Abstract:

Abstract Casestudy: Invasive urothelial carcinoma is heterogenous entity and show variant morphologic patterns, of which squamous differentiation is the most common. Other variants have been widely recognized and studied. Invasive urothelial carcinoma with chordoid features is a rare entity with only 16 reported cases to date in English literature. It has a significant morphologic overlap with other vesical and non-vesical myxoid neoplasms, including extra-skeletal myxoid chondrosarcoma and chordoma, which necessitate an extensive workup to reach an accurate diagnosis. To the best of our knowl

APA, Harvard, Vancouver, ISO, and other styles

49

Çamtosun, Ahmet, Huseyin Çelik, Ramazan Altıntaş, and Nusret Akpolat. "Primary Small Cell Carcinoma in Urinary Bladder: A Rare Case." Case Reports in Urology 2015 (2015): 1–3. http://dx.doi.org/10.1155/2015/789806.

Full text

Abstract:

Small cell carcinoma of bladder, which does not have a common and accepted treatment protocol, is a rare and highly aggressive tumor. It is mostly pulmonary originated; however, it can rarely be seen in extrapulmonary sites. We presented an interesting and uncommon case, in which the transitional cell tumor was found in the transurethral resection specimen, but the small cell carcinoma was detected in the final radical cystectomy material.

APA, Harvard, Vancouver, ISO, and other styles

50

Cunico, S. Cosciani, E. Frego, M. Scanzi, T. Zanotelli, E. Panizza, and P. Martucci. "Upper tract transitional cell carcinoma following or related to bladder cancer: Controversies." Urologia Journal 63, no. 1 (1996): 25–28. http://dx.doi.org/10.1177/039156039606300103.

Full text

Abstract:

— The incidence of upper urinary tract transitional cell carcinoma (UTTCC) following a bladder cancer has been studied in 1731 urothelial tumours from 1984 to 1995. The UTTCC were 88: 59 primitive, 6 synchronous and 23 metachronous after a bladder cancer (1672). Of the 23 metachronous UTTCC, 17 followed TURBT (17/1310 = 1.3%): the latency period was very long (64.8 months); grading and staging were mostly similar to the foregoing bladder tumours. A vesicoureteral reflux raised the metachronous UTTCC rate to 17.6%. A neoplastic distal ureter was found during radical cystectomy in 2.24%. During

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!